Meta facebook tracking pixel
Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Register

For Breast Cancer

  1. Register

For Leukemia

  1. Register

For Melanoma

  1. Register

For Pancreatic Cancer

  1. Register

Past workshops

For All Cancers

    1. Managing Eye and Vision Changes Related to Cancer Treatments
    2. Understanding the Different Names for Biomarker Testing & Their Role in Selecting the Best Treatment for YouPart II of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
    3. Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
    4. Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of CancerPart I of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
    5. Diverse Populations Participating in Decisions About Your Care With Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
    6. Understanding Diagnostic Technologies and Biomarkers
    7. Clinical Trials: How They Transform the Treatment of Cancer
    8. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
    9. Understanding Diagnostic Technologies and Biomarkers
    10. Chemotherapy Treatment Side Effects: Prevention & Management
    11. Clinical Trials: How They Transform the Treatment of Cancer
    12. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    13. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
    14. Preventing, Managing & Treating Infection in Adults Living with Cancer
    15. How Health Care Disparities May Influence Your Cancer Treatment & Care
    16. Cancer and Flu Shots
    17. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    18. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    19. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
    20. Understanding the Costs of Care and Your Health Care CoveragePart II of Life with Cancer: A Guide to Getting the Best Care
    21. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health

For Acute Lymphoblastic Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    3. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    4. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    5. Update on CAR T-Cell Therapies
    6. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    7. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    8. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    9. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    12. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    13. Transplantation as a Treatment Option for Blood Cancers

For Acute Myeloid Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR T-Cell Therapies
    4. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    5. Acute Myelogenous Leukemia (AML): Current Treatment Perspectives
    6. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Acute Myeloid Leukemia (AML): Treatment Updates
    10. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    11. Transplantation as a Treatment Option for Blood Cancers

For Basal Cell Cancer

    1. Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatesPart I of Living with Bladder Cancer
    2. Bladder Cancer: Treatment Updates
    3. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer

For Bone Cancer

    1. Diverse Populations Living with Multiple Myeloma: Treatment Advances
    2. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Brain Cancer

    1. Glioblastoma in Adults: Treatment Updates
    2. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting

For Breast Cancer

    1. Breast Cancer in Younger Women: New Treatment Options
    2. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    3. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    4. Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
    5. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    6. 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
    7. Metastatic Breast Cancer: Treatment Updates
    8. Early Stage Breast Cancer: New Treatment Approaches
    9. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    10. Lobular Breast Cancer: Treatment Progress
    11. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    12. Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    14. Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    16. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    17. Metastatic Breast Cancer: Treatment Updates
    18. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    19. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    20. The Role of Radiation Therapy in the Treatment of Breast Cancer
    21. Metastatic Breast Cancer in African Americans: New Treatments

For Cervical Cancer

    1. Advances in the Treatment of Cervical Cancer
    2. Cervical Cancer: Treatment Advances
    3. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    4. Cervical Cancer: Treatment Advances

For Chronic Lymphocytic Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR T-Cell Therapies
    4. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    5. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    6. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
    10. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    11. Transplantation as a Treatment Option for Blood Cancers

For Chronic Myelogenous Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR T-Cell Therapies
    4. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    5. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    9. Transplantation as a Treatment Option for Blood Cancers

For Colorectal Cancer

    1. Advances in the Treatment of Colorectal Cancer
    2. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    3. Advances in the Treatment of Colorectal Cancer
    4. Advances in the Treatment of Colorectal Cancer
    5. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    6. Colorectal Cancer Treatment: Progress and Advances
    7. Advances in the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    17. Transplantation as a Treatment Option for Blood Cancers

For Diffuse Large B-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    3. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    4. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    5. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    6. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    7. Update on CAR T-Cell Therapies
    8. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    9. Non-Hodgkin Lymphoma: Current Treatment Progress
    10. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    11. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    12. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    13. Update On Marginal Zone Lymphoma (MZL)
    14. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    17. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Endometrial Cancer

    1. Progress in the Treatment of Endometrial Cancer
    2. Progress in the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. Update on Follicular Lymphoma
    2. CAR T-Cell Therapy: What’s New
    3. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    4. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    5. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    6. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    7. Update on CAR T-Cell Therapies
    8. Follicular Lymphoma: Treatment Progress
    9. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    10. Non-Hodgkin Lymphoma: Current Treatment Progress
    11. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    12. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    13. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    14. Update On Marginal Zone Lymphoma (MZL)
    15. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    18. Follicular Lymphoma: Treatment Progress
    19. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    20. Transplantation as a Treatment Option for Blood Cancers

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances
    5. Advances in the Treatment of Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances

For Glioblastoma

    1. Glioblastoma in Adults: Treatment Updates
    2. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting

For Head and Neck Cancer

    1. Oral, Head and Neck Cancer: Treatment Updates
    2. Oral, Head & Neck Cancer: Treatment Update
    3. Treatment Update in Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    17. Transplantation as a Treatment Option for Blood Cancers
    18. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

For Kidney Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Renal Cell Cancer: Treatment Advances

For Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    3. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    4. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    5. Update on CAR T-Cell Therapies
    6. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    7. Acute Myelogenous Leukemia (AML): Current Treatment Perspectives
    8. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    9. Chronic Lymphocytic Leukemia (CLL): Treatment Updates
    10. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    11. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    12. Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
    13. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. Acute Myeloid Leukemia (AML): Treatment Updates
    17. Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
    18. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    19. Transplantation as a Treatment Option for Blood Cancers
    20. Progress in the Treatment of Myelofibrosis

For Liver Cancer

    1. Liver Cancer: Treatment Update
    2. Liver Cancer: Treatment Updates

For Lung Cancer

    1. Non-Small Cell Lung Cancer: Biomarker Testing and TreatmentPart II of Living with Non-Small Cell Lung Cancer
    2. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
    3. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    4. Diverse Populations Living with Non-Small Cell Lung Cancer
    5. Update on Small Cell Lung CancerPart I of Living with Small Cell Lung Cancer
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    8. Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
    9. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    10. Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
    11. Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
    12. Non-Small Cell Lung Cancer: Treatment AdvancesPart I of Living with Non-Small Cell Lung Cancer
    13. Advances in the Treatment of Lung CancerPart I of Living with Lung Cancer
    14. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung CancerPart II of Living with Lung Cancer

For Lymphoma

    1. Update on Follicular Lymphoma
    2. CAR T-Cell Therapy: What’s New
    3. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    4. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    5. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    6. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    7. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    8. Update on CAR T-Cell Therapies
    9. Follicular Lymphoma: Treatment Progress
    10. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    11. Non-Hodgkin Lymphoma: Current Treatment Progress
    12. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    13. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    14. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    15. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    16. Update On Marginal Zone Lymphoma (MZL)
    17. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    18. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    21. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
    22. Follicular Lymphoma: Treatment Progress
    23. Marginal Zone Lymphoma (MZL): Treatment Updates
    24. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    25. Transplantation as a Treatment Option for Blood Cancers
    26. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    27. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma

For Mantle Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    11. Update On Marginal Zone Lymphoma (MZL)
    12. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    15. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
    16. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    17. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    18. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma

For Marginal Zone Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. Marginal Zone Lymphoma (MZL): Treatment Updates
    17. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    18. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

For Melanoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    2. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    4. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
    5. People of Color Living with Skin Cancer
    6. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Merkel Cell Carcinoma

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
    2. Mesothelioma: Innovative Treatment Options

For Metastatic Breast Cancer

    1. Breast Cancer in Younger Women: New Treatment Options
    2. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    3. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    4. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    5. 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
    6. Metastatic Breast Cancer: Treatment Updates
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Lobular Breast Cancer: Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    11. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    12. Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    14. Metastatic Breast Cancer: Treatment Updates
    15. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    16. The Role of Radiation Therapy in the Treatment of Breast Cancer
    17. Metastatic Breast Cancer in African Americans: New Treatments

For Multiple Myeloma

    1. Diverse Populations Living with Multiple Myeloma: Treatment Advances
    2. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    3. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    4. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    5. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    6. Progress in the Treatment of Multiple Myeloma
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    10. Transplantation as a Treatment Option for Blood Cancers

For Myelodysplastic Syndromes

    1. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    4. Transplantation as a Treatment Option for Blood Cancers

For Myelofibrosis

    1. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Progress in the Treatment of Myelofibrosis

For Myeloproliferative Neoplasms

    1. Managing Treatment Side Effects, Aches and Pains from Myeloproliferative Neoplasms (MPNs)Part II of Living with Myeloproliferative Neoplasms (MPNs)
    2. Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms (MPNs)
    3. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    4. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    7. Transplantation as a Treatment Option for Blood Cancers
    8. Progress in the Treatment of Myelofibrosis
    9. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

For Non-Hodgkin Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    17. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    18. Transplantation as a Treatment Option for Blood Cancers
    19. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

For Ovarian Cancer

    1. Update on the Treatment of Ovarian Cancer
    2. Ovarian Cancer: Treatment Updates
    3. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    4. Medical Update on Ovarian Cancer

For Pancreatic Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    2. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting

For Peripheral T-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    17. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

For Polycythemia Vera

    1. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers

For Prostate Cancer

    1. Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
    2. Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
    3. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    4. Advances in the Treatment of Metastatic Prostate Cancer

For Renal Cell Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Renal Cell Cancer: Treatment Advances

For Sarcoma

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
    2. People of Color Living with Skin Cancer

For Skin Cancer

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    2. Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
    3. People of Color Living with Skin Cancer
    4. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Small Lymphocytic Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
    5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    8. Non-Hodgkin Lymphoma: Current Treatment Progress
    9. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    11. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    12. Update On Marginal Zone Lymphoma (MZL)
    13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    16. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    17. Transplantation as a Treatment Option for Blood Cancers

For Squamous Cell Cancer

    1. Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
    2. People of Color Living with Skin Cancer
    3. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Stomach Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances

For Testicular Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting

For Thyroid Cancer

For Triple Negative Breast Cancer

    1. Breast Cancer in Younger Women: New Treatment Options
    2. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    3. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    4. Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
    5. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
    6. 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
    7. Metastatic Breast Cancer: Treatment Updates
    8. Early Stage Breast Cancer: New Treatment Approaches
    9. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    10. Lobular Breast Cancer: Treatment Progress
    11. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    12. Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    14. Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    16. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    17. Metastatic Breast Cancer: Treatment Updates
    18. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    19. The Role of Radiation Therapy in the Treatment of Breast Cancer
    20. Metastatic Breast Cancer in African Americans: New Treatments

For Uterine Cancer

    1. Progress in the Treatment of Endometrial Cancer
    2. Progress in the Treatment of Endometrial Cancer

For Vaginal Cancer

    1. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting

For Waldenstrom’s Macroglobulinemia

    1. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.